What Is Veracyte, Inc. (VCYT) Worth in 2026?
According to the CirclFi Deep Alpha Valuation Engine, Veracyte, Inc.'s intrinsic value is estimated at $19.60. Trading at its current price of $57.48, the valuation engine raises significant caution: 12 of 13 models flag downside risk, projecting an average implied return of -65.9%. Model dispersion is worth noting: PWERM targets $59.32 (+3.2%), versus Markov DDM at $3.10 (-94.6%). This +97.8% range highlights the importance of multi-model analysis rather than relying on any single methodology.
What Do the Models Say About VCYT?
13 of 13 models are currently active for VCYT. Of these, 1 model suggests upside while 12 models suggest overvaluation. The Bayesian DCF estimates VCYT's intrinsic value at $9.67, implying -83.2% downside from the current price. See which stocks rank higher →
How Does VCYT Rank in Services-Medical Laboratories?
Among 24 Services-Medical Laboratories stocks, VCYT ranks #2 by Quality of Company score. CirclFi's QOC score of 8.8/10 evaluates 32 fundamental signals. A score of 8.8 places VCYT in the top tier.
Veracyte, Inc. operates in a competitive landscape where fundamental quality metrics are key differentiators for long-term value creation.
Is VCYT a Value Trap?
CirclFi's Value Trap algorithm assigns VCYT a score of 23/100 (SAFE). This indicates minimal risk. Fundamentals are healthy. The score cross-references apparent undervaluation against fundamental deterioration signals. Browse lowest value-trap stocks →
Multi-Model Methodology
13 of 13 models are active for Veracyte, Inc.. Broad coverage provides high confidence. Each model applies a fundamentally different valuation philosophy. See the complete methodology →
According to the CirclFi Quality of Company (QOC) framework, Veracyte, Inc. earns a quality score of 8.8/10. This robust rating reflects the company's standing across 32 fundamental signals spanning profitability, growth consistency, balance sheet strength, and capital allocation efficiency.
The gap between the most bullish and bearish model spans +97.8% — demonstrating why single-model analysis is dangerous. Browse all stocks with 13-model coverage →
Data Sources & Confidence
Every VCYT valuation is built from SEC EDGAR XBRL filings — 700+ standardized financial tags. Macroeconomic context from FRED calibrates discount rates, while GDELT news sentiment feeds into our Sentiment SOTP model. All pipelines run daily. Read the complete data methodology →
Across VCYT's 13 active models, average confidence is 39%. Lower confidence may reflect limited history or high volatility.
CirclFi's output is a research starting point, not a buy/sell signal. All data updates daily. Read the full methodology →
Buy with Gumroad